Benefits
Potential benefits for you
The standard treatment for exacerbations is two antibiotics (beta-lactam and aminoglycoside). In this study, you might get a beta-lactam alone. This may treat your exacerbation without exposure to the risks of an aminoglycoside.
Potential benefits for others
Learning which antibiotic approach is best for outcomes and risks may benefit people with CF in the future.
About 730 people with CF will take part in this study at approximately 70 hospitals and clinics around the United States, Canada, and Europe. Once the study is completed, we will let you know how to get a summary of the results.